Journal of Medicinal Chemistry p. 1105 - 1131 (2020)
Update date:2022-08-15
Topics:
Kienle, Maryline
Eisenring, Patrick
Stoessel, Barbara
Horlacher, Oliver P.
Hasler, Samuel
Van Colen, Gwéna?lle
Hartkoorn, Ruben C.
Vocat, Anthony
Cole, Stewart T.
Altmann, Karl-Heinz
A series of derivatives of the antimycobacterial natural product pyridomycin have been prepared with the C2 side chain attached to the macrocyclic core structure by a C-C single bond, in place of the synthetically more demanding enol ester double bond found in the natural product. Hydrophobic C2 substituents of sufficient size generally provide for potent anti-Mtb activity of these dihydropyridomycins (minimum inhibitory concentration (MIC) values around 2.5 μM), with several analogs thus approaching the activity of natural pyridomycin. Surprisingly, some of these compounds, in contrast to pyridomycin, are insensitive to overexpression of InhA in Mycobacterium tuberculosis (Mtb). This indicates that their anti-Mtb activity does not critically depend on the inhibition of InhA and that their overall mode of action may differ from that of the original natural product lead.
View MoreBeijing Tianjia Chemical Science & Technology Co.,Ltd
Contact:86-0550-2392698
Address:No.388, Shiliang Road (East),
Contact:86-21 60347964
Address:No.1304, West Meilong Road, Minhang District, Shanghai, China
Hangzhou Donglou Bio-nutrient Co., Ltd.
Contact:+86-571-82225795,13967112289
Address:Louta Town, Xiaoshan,Hangzhou,Zhejiang
MS( MAOSHENG )Chemical CO.,LTD
Contact:+86-519-82726678.82726378
Address:TAOXI INDUSTRY ZONE JINTAN
Jiangsu Chiatai Qingjiang Pharmaceutical Co.,Ltd
Contact:+86-517-86283327
Address:9 North Hantai Road, Huaian, China
Doi:10.1016/0960-894X(96)00427-1
(1996)Doi:10.1021/ja01854a051
(1941)Doi:10.1039/CC9960002179
(1996)Doi:10.1002/anie.200600572
(2006)Doi:10.1021/np050378g
(2006)Doi:10.1002/zaac.19683630110
(1968)